• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨性别者预防性健康——胸部/乳腺癌筛查。

Transgender preventative health-chest/breast cancer screening.

作者信息

Bacot-Davis Valjean R, Moran Allison H

机构信息

Department of Medicine-Pediatrics, Stony Brook University Hospital, Stony Brook, NY, United States.

Department of Social Work, State University of New York at Albany, School of Social Welfare, Richardson Hall, Albany, NY, United States.

出版信息

Front Health Serv. 2024 Aug 14;4:1434536. doi: 10.3389/frhs.2024.1434536. eCollection 2024.

DOI:10.3389/frhs.2024.1434536
PMID:39206444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11349637/
Abstract

Cancer mortality rates have decreased over the last 48 years attributable to standardized cancer screenings. These screenings were developed without deliberate inclusion of transgender and non-binary populations. While specialists are familiar regarding cancer screening in this distinct population, those in primary care might be more limited. As such, we aimed to develop a screening risk tool that combines the Breast Cancer Risk Assessment Tool (Gail model) with the updated American College of Radiology Appropriateness Criteria-Transgender Breast Cancer Screening, into an online questionnaire designed to accommodate primary care physicians performing routine health screenings to advise appropriate imaging and referral for this population. This new tool can be used for transgender chest/breast risk assessment whereas the Gail model alone was developed without transgender populations in mind, with the aim of early detection and cancer prevention in this historically underserved healthcare population.

摘要

在过去48年中,由于标准化癌症筛查,癌症死亡率有所下降。这些筛查的开发并未特意纳入跨性别者和非二元性别者群体。虽然专科医生熟悉这一特殊人群的癌症筛查,但初级保健医生对此的了解可能较为有限。因此,我们旨在开发一种筛查风险工具,将乳腺癌风险评估工具(盖尔模型)与更新后的美国放射学会适宜性标准——跨性别者乳腺癌筛查相结合,形成一份在线问卷,供进行常规健康筛查的初级保健医生使用,以便为该人群提供适当的影像检查建议和转诊建议。这种新工具可用于跨性别者胸部/乳房风险评估,而单独的盖尔模型在开发时并未考虑跨性别者群体,其目的是在这一历来未得到充分服务的医疗人群中实现早期检测和癌症预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/11349637/f6930c95064d/frhs-04-1434536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/11349637/f6930c95064d/frhs-04-1434536-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556b/11349637/f6930c95064d/frhs-04-1434536-g001.jpg

相似文献

1
Transgender preventative health-chest/breast cancer screening.跨性别者预防性健康——胸部/乳腺癌筛查。
Front Health Serv. 2024 Aug 14;4:1434536. doi: 10.3389/frhs.2024.1434536. eCollection 2024.
2
ACR Appropriateness Criteria® Transgender Breast Cancer Screening.ACR 适宜性标准®跨性别乳腺癌筛查。
J Am Coll Radiol. 2021 Nov;18(11S):S502-S515. doi: 10.1016/j.jacr.2021.09.005.
3
Opportunities and Gaps in Primary Care Preventative Health Services for Transgender Patients: A Systemic Review.为跨性别患者提供的初级保健预防性健康服务中的机遇与差距:一项系统综述。
Transgend Health. 2016 Nov 1;1(1):216-230. doi: 10.1089/trgh.2016.0019. eCollection 2016.
4
5
Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model.跨性别群体中的癌症筛查:当前指南、最佳实践及拟议照护模式综述
Transl Androl Urol. 2020 Dec;9(6):2771-2785. doi: 10.21037/tau-20-954.
6
Community-generated solutions to cancer inequity: recommendations from transgender, non-binary and intersex people on improving cancer screening and care.社区提出的解决癌症不平等问题的方案:跨性别者、非二元性别者和双性人关于改善癌症筛查与护理的建议。
BMJ Oncol. 2023;2(1). doi: 10.1136/bmjonc-2022-000014.
7
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.针对40至49岁患乳腺癌平均风险女性的乳腺钼靶筛查:一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.
8
Breast Imaging in Transgender Patients.transgender患者的乳腺成像
J Breast Imaging. 2020 Mar 25;2(2):161-167. doi: 10.1093/jbi/wbz092.
9
Breast Cancer Screening Recommendations for Transgender and Gender Diverse Patients: A Knowledge and Familiarity Assessment of Primary Care Practitioners.乳腺癌筛查推荐用于跨性别和性别多样化患者:初级保健从业者的知识和熟悉度评估。
J Community Health. 2023 Oct;48(5):889-897. doi: 10.1007/s10900-023-01228-2. Epub 2023 May 23.
10
Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.跨性别成年人的癌症筛查率:初级保健数据的横断面分析。
Can Fam Physician. 2019 Jan;65(1):e30-e37.

本文引用的文献

1
Why do transgender individuals experience discrimination in healthcare and thereby limited access to healthcare? An interview study exploring the perspective of German transgender individuals.为什么跨性别者在医疗保健中会受到歧视,从而限制了他们获得医疗保健的机会?一项探索德国跨性别者观点的访谈研究。
Int J Equity Health. 2023 Oct 10;22(1):211. doi: 10.1186/s12939-023-02023-0.
2
Breaking Healthcare Barriers for Transgender Individuals With Rare Tumor Presentation.打破罕见肿瘤表现的跨性别者的医疗障碍。
Cureus. 2023 Jan 15;15(1):e33791. doi: 10.7759/cureus.33791. eCollection 2023 Jan.
3
Perceptions of Transgender and Nonbinary Persons Toward Breast and Cervical Cancer Development, Screening, and Potential Impact on Gender-Affirming Hormone Therapy.
跨性别和非二元性别者对乳腺癌和宫颈癌的发生、筛查的认知,以及对性别肯定激素治疗的潜在影响。
JCO Oncol Pract. 2023 May;19(5):e794-e800. doi: 10.1200/OP.22.00681. Epub 2023 Feb 17.
4
Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis.transgender 个体患乳腺癌的风险与发病率:一项系统评价与荟萃分析
Eur J Cancer Prev. 2023 May 1;32(3):207-214. doi: 10.1097/CEJ.0000000000000784. Epub 2023 Feb 16.
5
Affirming Care for Transgender Patients.确认对跨性别患者的关怀。
Med Clin North Am. 2023 Mar;107(2):371-384. doi: 10.1016/j.mcna.2022.10.011.
6
Health Communication and Sexual Orientation, Gender Identity, and Expression.卫生保健传播与性倾向、性别认同和表达。
Med Clin North Am. 2022 Jul;106(4):589-600. doi: 10.1016/j.mcna.2021.12.005. Epub 2022 May 28.
7
Use and Applicability of the Gail Model to Calculate Breast Cancer Risk: A Scoping Review.使用盖尔模型计算乳腺癌风险的情况和适用性:范围综述。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1117-1123. doi: 10.31557/APJCP.2022.23.4.1117.
8
ACR Appropriateness Criteria® Transgender Breast Cancer Screening.ACR 适宜性标准®跨性别乳腺癌筛查。
J Am Coll Radiol. 2021 Nov;18(11S):S502-S515. doi: 10.1016/j.jacr.2021.09.005.
9
Progress Against Cancer Mortality 50 Years After Passage of the National Cancer Act.《国家癌症法案》通过 50 年后癌症死亡率的进展。
JAMA Oncol. 2022 Jan 1;8(1):156-159. doi: 10.1001/jamaoncol.2021.5668.
10
Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.新加坡全国范围内 24431 名女性的乳腺 X 线筛查乳腺癌风险分层:一项全国性筛查队列研究。
Cancer Med. 2021 Nov;10(22):8182-8191. doi: 10.1002/cam4.4297. Epub 2021 Oct 28.